A new negative pressure ventilation assistance device using knowledge developed by Marshall Aerospace and Defence Group during the Covid-19 pandemic looks set to go into mass production thanks to a new partnership with Indian based ventilator manufacturer Skanray.
The non-invasive Marshall Exovent-19 prototype negative pressure ventilation assistance device was developed to provide additional treatment options for any patient with respiratory failure, including those with COVID-19, with the benefit of offering greater patient comfort as they don’t need to be asleep or have an artificial airway in place.